300601.SZ
康泰生物
SZSE · Healthcare · C 制造业 · CN
CNY 12.62
−3.15%Margins
Gross margin
74.1%
EBITDA margin
17.7%
EBIT margin
1.9%
Net margin
3.1%
FCF margin
9.2%
0.8%
Return on equity
0.6%
Return on assets
0.5%
Return on invested capital
0.19x
Asset turnover
CNY 582.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026